NO20084363L - 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister - Google Patents
2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonisterInfo
- Publication number
- NO20084363L NO20084363L NO20084363A NO20084363A NO20084363L NO 20084363 L NO20084363 L NO 20084363L NO 20084363 A NO20084363 A NO 20084363A NO 20084363 A NO20084363 A NO 20084363A NO 20084363 L NO20084363 L NO 20084363L
- Authority
- NO
- Norway
- Prior art keywords
- benzylphthalazine
- histamine
- antagonists
- derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0607839A GB0607839D0 (en) | 2006-04-20 | 2006-04-20 | Compounds |
GB0706176A GB0706176D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
GB0706160A GB0706160D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
PCT/EP2007/053773 WO2007122156A1 (en) | 2006-04-20 | 2007-04-18 | 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084363L true NO20084363L (no) | 2008-11-17 |
Family
ID=38226516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084363A NO20084363L (no) | 2006-04-20 | 2008-10-17 | 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister |
Country Status (19)
Country | Link |
---|---|
US (2) | US20080039444A1 (es) |
EP (1) | EP2007735B1 (es) |
JP (1) | JP4489143B2 (es) |
KR (1) | KR20090007604A (es) |
AR (1) | AR060535A1 (es) |
AT (1) | ATE486063T1 (es) |
AU (1) | AU2007242842A1 (es) |
BR (1) | BRPI0710156A2 (es) |
CA (1) | CA2649029A1 (es) |
CO (1) | CO6140030A2 (es) |
CR (1) | CR10356A (es) |
DE (1) | DE602007010118D1 (es) |
EA (1) | EA200801996A1 (es) |
MA (1) | MA30405B1 (es) |
MX (1) | MX2008013406A (es) |
NO (1) | NO20084363L (es) |
PE (1) | PE20080360A1 (es) |
TW (1) | TW200811116A (es) |
WO (1) | WO2007122156A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20071068A1 (es) | 2005-12-20 | 2007-12-13 | Glaxo Group Ltd | Acido 3-(4-{[4-(4-{[3-(3,3-dimetil-1-piperidinil)propil]oxi}fenil)-1-piperidinil]carbonil}-1-naftalenil)propanoico o propenoico, sales de los mismos, como antagonistas de los receptores h1 y h3 |
US20100184770A1 (en) * | 2006-12-20 | 2010-07-22 | Glaxo Group Limited | Compounds |
PE20091089A1 (es) * | 2007-10-16 | 2009-08-24 | Glaxo Group Ltd | Composiciones farmaceuticas que comprenden 4-[(4-clorofenil)metil]-2-({(2r)-1-[4-(4{[3-(hexahidro-1h-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2h)-ftalazinona y furoato de fluticasona |
SG190667A1 (en) | 2008-05-23 | 2013-06-28 | Panmira Pharmaceuticals Llc | 5-lipoxygenase-activating protein inhibitor |
GB0811447D0 (en) * | 2008-06-20 | 2008-07-30 | Glaxo Group Ltd | Formulations |
WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
US20120157446A1 (en) * | 2009-06-29 | 2012-06-21 | Glaxo Group Limited | Medical use |
EP2571868B1 (en) | 2010-05-19 | 2016-05-04 | Sandoz AG | Preparation of posaconazole intermediates |
WO2011144655A1 (en) | 2010-05-19 | 2011-11-24 | Sandoz Ag | Process for the preparation of chiral hydrazides |
EP2571869B1 (en) * | 2010-05-19 | 2015-09-23 | Sandoz AG | Purification of posaconazole and posaconazole intermediates |
WO2012045729A1 (en) | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
WO2012072512A1 (en) | 2010-11-29 | 2012-06-07 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists |
US8754101B2 (en) | 2011-04-11 | 2014-06-17 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists |
CN108329303A (zh) | 2011-06-16 | 2018-07-27 | 桑多斯股份公司 | 制备手性化合物的方法 |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
CN107072976A (zh) | 2014-05-12 | 2017-08-18 | 葛兰素史克知识产权第二有限公司 | 用于治疗传染性疾病的包含Danirixin的药物组合物 |
BR112022019245A2 (pt) | 2020-03-26 | 2022-11-16 | Glaxosmithkline Ip Dev Ltd | Inibidores de catepsina para prevenir ou tratar infecções virais |
EP4346815A1 (en) * | 2021-05-27 | 2024-04-10 | Schrödinger, Inc. | Heterocyclic compounds and methods of use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH572914A5 (es) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
US3813384A (en) * | 1972-01-17 | 1974-05-28 | Asta Werke Ag Chem Fab | Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof |
EP0174464B1 (de) * | 1984-09-14 | 1990-01-03 | ASTA Pharma AG | Substituierte Benzylphthalazinon-Derivate |
EP0222191B1 (de) * | 1985-11-11 | 1991-01-30 | ASTA Pharma AG | 4-Benzyl-1-(2H)-phthalazinon-Derivate |
EP0289939A1 (de) * | 1987-05-08 | 1988-11-09 | ASTA Pharma AG | Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest |
CZ199593A3 (en) * | 1992-10-02 | 1994-04-13 | Asta Medica Ag | Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr) |
DE69912379T2 (de) * | 1998-08-14 | 2004-05-06 | Pfizer Inc. | Antithrombosemittel |
US6180629B1 (en) * | 1998-08-14 | 2001-01-30 | Cell Pathways, Inc. | [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
GB0224084D0 (en) * | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
CN1787818A (zh) * | 2003-03-18 | 2006-06-14 | 麦克公司 | 趋化因子受体活性的氨基环丁基酰胺调节剂 |
EP1642898B1 (en) * | 2003-06-27 | 2013-03-27 | Msd K.K. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
-
2007
- 2007-04-18 JP JP2009505878A patent/JP4489143B2/ja not_active Expired - Fee Related
- 2007-04-18 MX MX2008013406A patent/MX2008013406A/es not_active Application Discontinuation
- 2007-04-18 EP EP07728235A patent/EP2007735B1/en active Active
- 2007-04-18 AU AU2007242842A patent/AU2007242842A1/en not_active Abandoned
- 2007-04-18 US US11/736,602 patent/US20080039444A1/en not_active Abandoned
- 2007-04-18 AT AT07728235T patent/ATE486063T1/de not_active IP Right Cessation
- 2007-04-18 EA EA200801996A patent/EA200801996A1/ru unknown
- 2007-04-18 DE DE602007010118T patent/DE602007010118D1/de active Active
- 2007-04-18 WO PCT/EP2007/053773 patent/WO2007122156A1/en active Application Filing
- 2007-04-18 PE PE2007000478A patent/PE20080360A1/es not_active Application Discontinuation
- 2007-04-18 CA CA002649029A patent/CA2649029A1/en not_active Abandoned
- 2007-04-18 US US12/297,458 patent/US20090105225A1/en not_active Abandoned
- 2007-04-18 AR ARP070101668A patent/AR060535A1/es not_active Application Discontinuation
- 2007-04-18 BR BRPI0710156-2A patent/BRPI0710156A2/pt not_active Application Discontinuation
- 2007-04-18 KR KR1020087028456A patent/KR20090007604A/ko not_active Application Discontinuation
- 2007-04-18 TW TW096113665A patent/TW200811116A/zh unknown
-
2008
- 2008-10-07 CR CR10356A patent/CR10356A/es not_active Application Discontinuation
- 2008-10-15 CO CO08110028A patent/CO6140030A2/es unknown
- 2008-10-17 NO NO20084363A patent/NO20084363L/no not_active Application Discontinuation
- 2008-11-10 MA MA31370A patent/MA30405B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CO6140030A2 (es) | 2010-03-19 |
CA2649029A1 (en) | 2007-11-01 |
AR060535A1 (es) | 2008-06-25 |
WO2007122156A9 (en) | 2008-01-24 |
EA200801996A1 (ru) | 2009-04-28 |
AU2007242842A1 (en) | 2007-11-01 |
TW200811116A (en) | 2008-03-01 |
DE602007010118D1 (de) | 2010-12-09 |
US20080039444A1 (en) | 2008-02-14 |
US20090105225A1 (en) | 2009-04-23 |
BRPI0710156A2 (pt) | 2012-06-05 |
PE20080360A1 (es) | 2008-05-22 |
JP2009534351A (ja) | 2009-09-24 |
MX2008013406A (es) | 2008-11-04 |
JP4489143B2 (ja) | 2010-06-23 |
CR10356A (es) | 2008-11-26 |
WO2007122156A1 (en) | 2007-11-01 |
ATE486063T1 (de) | 2010-11-15 |
EP2007735A1 (en) | 2008-12-31 |
KR20090007604A (ko) | 2009-01-19 |
MA30405B1 (fr) | 2009-05-04 |
EP2007735B1 (en) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084363L (no) | 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
MX2009002171A (es) | Derivados de triazol como inhibidores de cinasas. | |
NO20082496L (no) | Pyrazinderivater | |
NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
WO2008094992A3 (en) | 2-aminopyridine derivatives useful as kinase inhibitors | |
NO20084005L (no) | Aminderivater | |
IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
NO20083919L (no) | Pyridin- og pyrimidinderivater som mGluR2-antagonister | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
NO20092342L (no) | Azaspiroderivativater | |
WO2009021965A3 (en) | Substituted quinoline derivatives as h1 receptor antagonists | |
NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
EA201100503A1 (ru) | Глюкозидные производные и их применения | |
NO20076197L (no) | Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander | |
NO20071521L (no) | Nye fenylaminopyrimidin derivater som hemmere av BCR-ABL kinase | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
NO20084872L (no) | 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig | |
NO20090266L (no) | Piperazinylderivater anvendelige i behandlingen av GPR38 receptormedierte sykdommer | |
WO2008074803A8 (en) | 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |